THUMPD3 regulates alternative splicing of ECM transcripts in human lung cancer cells and promotes proliferation and migration
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0314655 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Marie Klimontova und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge, United Kingdom. Hauptthemen laut MEDLINE: Cell Proliferation, Cell Movement, Alternative Splicing, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Cancer Research UK, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
RNA-modifying enzymes have recently garnered considerable attention due to their relevance in cancer biology, identifying them as potential targets for novel therapeutic intervention. THUMPD3 was recently identified as an RNA methyltransferase catalysing N 2 -methylguanosine (m 2 G) within certain tRNAs. In this study, we unveil a novel role for THUMPD3 in lung cancer cells. Depletion of the enzyme from lung cancer cells significantly impairs their fitness, negatively impacting key cellular processes such as proliferation and migration. Notably, exogenous expression of THUMPD3 in normal lung fibroblasts stimulates their proliferation rate. Additionally, transcriptome-wide analyses reveal that depletion of THUMPD3 from lung cancer cells induces substantial changes in the expression of cell surface proteins, including those comprising the extracellular matrix (ECM). We further demonstrate that THUMPD3 maintains expression of an extra-domain B (EDB) containing pro-tumour isoform of Fibronectin-1 mRNA, encoding FN1, an important ECM protein. Crucially, depletion of THUMPD3 promotes an alternative splicing event that removes the EDB-encoding exon from Fibronectin-1 . This is consistent with THUMPD3 depletion reducing cellular proliferation and migration. Moreover, depletion of THUMPD3 selectively and preferentially affects the alternative splicing of ECM and cell adhesion molecule encoding transcripts, as well as those encoding neurodevelopmental proteins. Overall, these findings highlight THUMPD3 as an important player in regulating cancer-relevant alternative splicing and they provide a rationale for further investigations into THUMPD3 as a candidate target in anti-cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
- STORM Therapeutics Ltd., Babraham Research Campus, Cambridge, United Kingdom.
- Department of Chemistry and Centre for Research on Biomolecular Interactions, York University, Toronto, ON, Canada.
- Milner Therapeutics Institute, University of Cambridge, Cambridge, United Kingdom.
ORCID-Profile: Marie Klimontova, Kimberley Chung Kim Chung, Ryan Hili, Andrew J Bannister
Förderung
- Wellcome Trust
- Cancer Research UK
- Natural Sciences and Engineering Research Council of Canada
- Ontario Ministry of Research and Innovation
- Canada Foundation for Innovation
Zitieren
APA
Klimontova, M., Zhang, H., Campos-Laborie, F., Webster, N., Andrews, B., Kim Chung, K. C., Hili, R., Kouzarides, T., & Bannister, A. J. (2024). THUMPD3 regulates alternative splicing of ECM transcripts in human lung cancer cells and promotes proliferation and migration. PLOS ONE. https://doi.org/10.1371/journal.pone.0314655
Vancouver
Klimontova M, Zhang H, Campos-Laborie F, Webster N, Andrews B, Kim Chung KC, et al. THUMPD3 regulates alternative splicing of ECM transcripts in human lung cancer cells and promotes proliferation and migration. PLOS ONE. 2024. doi:10.1371/journal.pone.0314655
BibTeX
@article{Klimontova2024,
author = {Klimontova, Marie and Zhang, Han and Campos-Laborie, Francisco and Webster, Natalie and Andrews, Byron and Kim Chung, Kimberley Chung and Hili, Ryan and Kouzarides, Tony and Bannister, Andrew J},
title = {THUMPD3 regulates alternative splicing of ECM transcripts in human lung cancer cells and promotes proliferation and migration},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0314655}
}
EUVIMED